Outpatient cardiac catheterisation (original) (raw)
Related papers
Outpatient cardiac catheterization: a report of 3,000 cases
Clinical cardiology, 1991
A total of 3000 patients have had cardiac catheterization in the Andreas Gruentzig Cardiovascular Laboratory of the Emory Clinic. The purpose of this presentation is 10 describe the patient population selected for this procedure and our experience with this group. The concept of catheterization as an outpatient is attractive from the standpoint of cost savings and time conservation. Safety has been questioned. We have found that this technique can be performed safely in carefully selected outpatients. Careful selection attempted to eliminate those with unstable symptoms, recent myocardial infarction, severe diabetes, and reniil failure. Small catheters were used to minimize the potential for bleeding. Excellent opacification of vessels was obtained with these catheters. Despite careful screening we found 2.2% had significant left main obstruction, 10.8% had triple-vessel disease, 16.0% had double-vessel disease, and 23.5% had single-vessel disease, and a similar percentage had normal coronary arteriograms. Our patients experienced ventricular fibrillation on five occasions, there were two small cerebral emboli with reversible neurologic defects, two episodes of pulmonary edema, and two episodes of severe allergic reactions. Only three palients had significant groin bleeding at home that required compression of the site. We subsequently did angioplasty on 323 patients, performed cardiac surgery (mostly coronary bypass) on 187 patients, and admitted 18.2% tvf the entire group. We conclude that this procedure can be done safely in this carefully designed setting and it saves time and offers cost savings. Patient selection is very important to minimize potential emergency situations and complications. The laboratory must be carefully set up
Heart, 1986
The uptake of cardiac catheterisation and operation and of permanent pacemaker implantation in a district hospital in Surrey from 1979 to 1984 was studied prospectively. The 1982-84 figures for coronary artery operation indicated that 362 procedures/million population/annum were needed in the district. If patients with >,New York Heart Association grade II angina only received operation the corresponding figure would have been 325. The national need for these procedures (464/million population/year) was estimated by correcting for the low standardised mortality ratio for ischaemic heart disease in the health district that was studied. Valvular heart disease accounted for 79 operations/million population/annum and permanent pacemaker insertion for 87 procedures/million population/annum. These figures underline the substantial shortfall in modern cardiac care in the United Kingdom.
Feasibility and cost-saving potential of outpatient cardiac catheterization
Journal of the American College of Cardiology, 1990
To determine the feasibility and cost-saving potential of substituting outpatient for inpatient cardiac catheterization, 986 consecutive procedures were studied at a large referral hospital. Patients were classified prospectively as to their eligibility for outpatient cardiac catheterization according to published guidelines. Resource consumption was recorded, and cost savings were then calculated by analyzing the specific supply and personnel costs that could change as a result of inpatient versus outpatient status.
European Journal of Cardiovascular Nursing
Background: Vascular complications are still common in the catheterization laboratory setting. However, no risk scores for their prediction have been described. With a view to bridging this gap, the present study sought to develop and validate a score for prediction of vascular complications associated with arterial access in patients undergoing interventional cardiology procedures. Methods: This prospective multicenter cohort study included adult patients who underwent cardiac catheterization via the femoral or radial route. The outcomes of interest were: access site hematoma; major and minor bleeding; and retroperitoneal hemorrhage, pseudoaneurysm, or arteriovenous fistula requiring surgical repair. Past medical history as well as pre-procedural, intra-procedural, and post-procedural variables were collected. Patients were randomly allocated to the derivation or validation cohorts at a 2:1 ratio. The following equation constituted the score: (>6F introducer sheath×4.0)+(percutaneous coronary intervention×2.5)+(history of vascular complication after prior interventional cardiology procedure×2.0)+(prior use of warfarin or phenprocoumon×2.0)+(female sex×1.5)+(age⩾60 years×1.5). The maximum score is 13.5 points. Results: A score dichotomized at ⩾3 (best cutoff for balancing sensitivity and specificity) was moderately accurate (sensitivity=0.66 (95% confidence interval: 0.59-0.73); specificity=0.59 (95% confidence interval: 0.56-0.61)). Patients with a score ⩾3 were at increased risk of complications (odds ratio: 2.95; 95% confidence interval: 2.22-3.91). Conclusions: This study yielded a score that is capable of predicting vascular complications and easily applied in daily practice by providers working in the catheterization laboratory setting.
Complications of cardiac catheterization in the current era: A single-center experience
Catheterization and Cardiovascular Interventions, 2001
Consecutive cardiac catheterization procedures done over a 2-yr period (April 1996 to March 1998) were prospectively analyzed to determine and characterize procedurerelated complications (in-hospital and 1-mo follow-up), as they occur at present. During the study period, 11,821 procedures (7,953 diagnostic and 3,868 therapeutic) were performed. The majority of procedures (> 60%) were done in high-risk patients. Stents were implanted in 33% of patients, and adjunctive abciximab was used in 6.6% of therapeutic procedures. The overall complication rate was 8% (3.6% of diagnostic procedures and 15.1% of therapeutic procedures). The procedure-related mortality rates were 0.2%, 0.1%, and 0.5% for total, diagnostic, and therapeutic procedures, respectively. Cardiac complications were seen in 3.9% (1.5% of diagnostic and 9% of therapeutic procedures). Emergency cardiac surgery was required in 0.05% of the diagnostic procedure group and 0.3% of the therapeutic procedure group (total, 0.1%). Despite marked changes in patient population and practice, the complication rates of cardiac catheterization remain very low. Cathet Cardiovasc Intervent 2001;52:289 -295.
The risks of waiting for cardiac catheterization: a prospective study
Background: Few large, systematic, prospective studies have documented the characteristics and clinical outcomes of patients awaiting cardiac catheterization and the delays that they experience. The primary objective of this study was to quantify the waiting times, morbidity and mortality of patients waiting for catheterization. A secondary objective was to identify predictors of cardiac events that occur while patients are waiting. Methods: A computerized, prospective, central waiting list registry was developed at a regional centre in Hamilton, Ont., serving 2.2 million people in southern Ontario. Between Apr. 1, 1998, and Mar. 31, 2000, 8030 consecutive patients (4725 outpatients and 3305 inpatients) were referred for cardiac catheterization. Major cardiac outcomes while on the waiting list (death, myocardial infarction and congestive heart failure) were documented prospectively and related to requested versus actual waiting time. Results: Most of the referrals (7345 [91.5%]) were for a primary diagnosis of suspected coronary artery disease. The median waiting time was 6 (interquartile range [IQR] 4) days for inpatients and 60 (IQR 68) days for outpatients. Actual waiting times correlated with the waiting times requested by the referring physicians. However, only 37% of the procedures overall were completed within the requested waiting time. Of the 8030 patients, 50 (0.6%) died, 32 (0.4%) had a myocardial infarction and 41 (0.5%) experienced congestive heart failure. Overall, 109 patients (1.4%) had a major cardiac event, namely, death, myocardial infarction or congestive heart failure. These events occurred over a median wait of 27 days (2 days for inpatients and 35 days for outpatients), and over half (57%) occurred within the waiting time requested by the referring physician. In the multivariate analysis, predictors of the composite of death, myocardial infarction or congestive heart failure were increasing age (relative risk [RR] 2.39, 95% confidence interval [CI] 1.52-3.75) and New York Heart Association class III/IV symptoms (RR 2.86, 95% CI 1.11-7.33) in inpatients, and increasing age (RR 1.36, 95% CI 1.12-1.66), aortic stenosis (RR 3.70, 95% CI 1.93-7.08) and left ventricular ejection fraction less than 35% (RR 4.35, 95% CI 2.48-7.61) in outpatients. Interpretation: Patients awaiting cardiac catheterization may experience major ad-
Interventional Cardiology and Surgery
Objective: To determine the predictors of time between presentation and primary angioplasty and the influence of this delay time on in-hospital mortality in clinical practice. Design: Analysis of data from the registry of percutaneous coronary interventions in acute myocardial infarction of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK). Patients: Data of 4815 patients registered at 80 hospitals between 1994 and 2000 were analysed.